Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication

Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it has taken hold. But promising results from a recent clinical trial suggest that broadly neutralizing antibody therapy (bNAbs) may be able to accomplish the next best thing.